Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
about
Hepatitis C virus hijacks host lipid metabolismNAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenTargeting host factors: A novel rationale for the management of hepatitis C virusMolecular mechanisms of insulin resistance in chronic hepatitis CHepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Production and pathogenicity of hepatitis C virus core gene products.Mechanisms and significance of liver steatosis in hepatitis C virus infectionInsulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.HCV 3a core protein increases lipid droplet cholesteryl ester content via a mechanism dependent on sphingolipid biosynthesis.Fluorescence lifetime imaging of alterations to cellular metabolism by domain 2 of the hepatitis C virus core protein.Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stressNew treatments for chronic hepatitis C.Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistanceMetabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).Hepatitis C virus infection: Are there still specific problems with genotype 3?PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β.Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity.Peroxisome proliferator-activated receptors and hepatitis C virus-induced insulin resistanceMetabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus InfectionApplication of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virusInsulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.PPAR and liver injury in HIV-infected patients.Steatosis and insulin resistance in hepatitis C: a way out for the virus?Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation.Interaction between hepatitis C virus and metabolic factors.Immunologic, metabolic and genetic factors in hepatitis C virus infection.Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.Hepatitis C virus diversity and hepatic steatosis.Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?Is genotype 3 of the hepatitis C virus the new villain?An insight into the diagnosis and pathogenesis of hepatitis C virus infection.Hepatitis C and lipid metabolism, hepatic steatosis, and NAFLD: still important in the era of direct acting antiviral therapy?Peroxisome proliferator-activated receptors and hepatitis C virusGenotype 3 Infection: The Last Stand of Hepatitis C Virus.Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infection.Insulin resistance, steatosis and hepatitis C virus.
P2860
Q24652319-57435742-5BDC-4AC0-9C29-F500E08752D0Q26745576-B0C0A980-6922-4977-943B-5F5748415660Q26861095-04EB9035-DF69-4191-A243-E0427B6648BFQ27488999-4AC0F91D-D05E-445C-8009-5AE34DC05F6AQ27489665-844E1784-8390-4DA1-98BD-3B88D00346E7Q30360538-5AE5615C-9ABD-4DB2-BCA3-30286B095D95Q33780095-01E50B6C-76CE-43FC-8E96-14BA39E3ABFFQ33866272-89090922-B301-4676-AA41-D4F90D822AD1Q34467208-2EF1B75E-E1DB-44FB-BF95-DE5BFCF8CD4AQ34734158-3E60439A-E008-4E9F-86E0-F8CC8ED6CB1BQ34795900-6ABA3DBD-389D-4248-92B0-D8B707F06DF5Q35259669-0779E827-CF3C-45E3-8D5C-A6840AAD0FEEQ35833006-EE9DC164-963E-446E-B52C-127DA7CC62B6Q36023170-365B10AD-D2CB-43FC-B8D9-48F9875D8F44Q36026554-6A1D274F-9ABD-471B-A300-7ED455DB887FQ36248995-A2F6D474-A3A5-4CFB-A40F-6DC47FFC4A7EQ36269670-92293ED7-8A70-48DC-8290-65D7E8AED8A2Q36330881-122C14C1-C98F-44D3-BBA8-5A6A65F3A98FQ36347839-AD305A6B-85E8-44A9-B8D2-74022B4FA9B4Q36364689-D3752E24-5619-403E-B6DA-4FE01E6B0C6BQ37037509-95BAF519-C026-46FC-B343-AFC7CCFFF7E3Q37151984-80F6A7D4-9D88-41C7-80AC-75D00E5596DEQ37190820-D3D0DE06-4002-45FA-8F50-7318ECB5ECC1Q37228658-0EC251B3-6CC0-4425-8AB4-0E9C7CEAA1B9Q37458203-F115E282-E1D6-401D-8012-A7AC97F29DBCQ37622162-71639F2E-4706-4776-85DE-556E436AC7CAQ37643968-20AE8066-520B-4079-A1B2-E543086CB9B9Q37654443-1C9FEB75-FBC8-4CFC-A5B6-0E553E971F65Q37682496-4ACC9990-4457-4E03-B977-BBA0ECD193DBQ37788976-F109A51C-0B64-4608-90D8-1332B51A30F0Q37980432-9A51F7DC-B02A-47E6-B24B-B8F0FFE344D7Q38072721-6A8B00B5-F666-48C9-B3C6-C757707F35F0Q38086739-2E445575-2237-4E98-BBD5-374C9E9B51F6Q38155123-D8CC9A9A-F0C0-4447-8F47-C58FD1299C75Q38168827-A84AD0F1-2E9E-4700-8E8A-E65C0532EC5DQ38170504-FCACCA1F-981A-48D3-ADBB-DC097CE18896Q38633502-B9AD8ED3-B6AA-46C0-BD5C-0AAACB8F6C99Q38772047-883C85E1-FD01-4612-986F-90AC76A638B3Q38848095-CE688766-865D-4C67-8201-A77D2185591AQ39240971-EABF146B-E389-49D2-B862-B17C1161CB7A
P2860
Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@en
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@nl
type
label
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@en
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@nl
prefLabel
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@en
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@nl
P2093
P2860
P1476
Peroxisome proliferator-activa ...... osis and genotype 3 infection.
@en
P2093
Hadengue A
Juge-Aubry CE
Rubbia-Brandt L
de Gottardi A
P2860
P304
P356
10.1111/J.1365-2036.2006.02729.X
P407
P577
2006-01-01T00:00:00Z